Common use of Trademarks and Patent Marking Clause in Contracts

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and shall ensure that the packaging, promotional materials, and labeling for Oragenics Products shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics shall ensure that Oragenics Products, or its packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics samples of Oragenics Product sold by Oragenics or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,9, Intrexon shall notify the result of such inspection to Oragenics in writing thereafter. Oragenics shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 3 contracts

Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Oragenics Inc)

AutoNDA by SimpleDocs

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and Fibrocell shall ensure that the packaging, promotional materials, and labeling for Oragenics Fibrocell Products and Improved Products shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ Fibrocell’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics Fibrocell shall ensure that Oragenics Fibrocell Products and Improved Products, or its their respective packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics Fibrocell shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ Fibrocell’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics Fibrocell acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics Fibrocell covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Fibrocell Product or Improved Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics Fibrocell samples of Oragenics Fibrocell Product or Improved Product sold by Oragenics Fibrocell or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Fibrocell Products or Improved Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.9, Intrexon shall notify the result of such inspection to Oragenics Fibrocell in writing thereafter. Oragenics Fibrocell shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks. Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission.

Appears in 3 contracts

Samples: Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.), Exclusive Channel Collaboration Agreement (Castle Creek Biosciences, Inc.), Exclusive Channel Collaboration Agreement (Fibrocell Science, Inc.)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and AquaBounty shall ensure that the packaging, promotional materials, and labeling for Oragenics Products AquaBounty Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ AquaBounty’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics AquaBounty shall ensure that Oragenics AquaBounty Products, or its their respective packaging or accompanying literature literature, as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics AquaBounty shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, materials in order to obtain Intrexon’s approval thereof. Oragenics’ AquaBounty’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics AquaBounty acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics AquaBounty covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics AquaBounty Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics AquaBounty samples of Oragenics AquaBounty Product sold by Oragenics AquaBounty or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics AquaBounty Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.8, Intrexon shall notify the result of such inspection to Oragenics AquaBounty in writing thereafter. Oragenics AquaBounty shall comply with commercially reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 3 contracts

Samples: Exclusive Channel Collaboration Agreement, Exclusive Channel Collaboration Agreement (AquaBounty Technologies, Inc.), Exclusive Channel Collaboration Agreement (AquaBounty Technologies, Inc.)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and AquaBounty shall ensure that the packaging, promotional materials, and Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. labeling for Oragenics Products AquaBounty Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ AquaBounty’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics AquaBounty shall ensure that Oragenics AquaBounty Products, or its their respective packaging or accompanying literature literature, as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics AquaBounty shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, materials in order to obtain Intrexon’s approval thereof. Oragenics’ AquaBounty’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics AquaBounty acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics AquaBounty covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics AquaBounty Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics AquaBounty samples of Oragenics AquaBounty Product sold by Oragenics AquaBounty or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics AquaBounty Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.8, Intrexon shall notify the result of such inspection to Oragenics AquaBounty in writing thereafter. Oragenics AquaBounty shall comply with commercially reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 2 contracts

Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and Genopaver shall ensure that the packaging, promotional materials, and labeling for Oragenics Products Genopaver Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ Genopaver’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics Genopaver shall ensure that Oragenics Products, or its packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Genopaver Products appropriately identify Intrexon Patent numbersPatents. Oragenics Genopaver shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ Genopaver’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics Genopaver acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics Genopaver covenants that it shall not Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Genopaver Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics Genopaver samples of Oragenics Genopaver Product sold by Oragenics Genopaver or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Genopaver Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.7, Intrexon shall notify the result of such inspection to Oragenics Genopaver in writing thereafter. Oragenics Genopaver shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 2 contracts

Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and Fibrocell shall ensure that the packaging, promotional materials, and labeling for Oragenics Fibrocell Products and Improved Products shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ Fibrocell’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics Fibrocell shall ensure that Oragenics Fibrocell Products and Improved Products, or its their respective packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics Fibrocell shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ Fibrocell’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics Fibrocell acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics Fibrocell covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Fibrocell Product or Improved Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics Fibrocell samples of Oragenics Fibrocell Product or Improved Product sold by Oragenics Fibrocell or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Fibrocell Products or Improved Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.9, Intrexon shall notify the result of such inspection to Oragenics Fibrocell in writing thereafter. Oragenics Fibrocell shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 2 contracts

Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and Soligenix shall ensure that the packaging, promotional materials, and labeling for Oragenics Products Soligenix Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ Soligenix’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics Soligenix shall ensure that Oragenics Soligenix Products, or its their respective packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics Soligenix shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ Soligenix’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics Soligenix acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics Soligenix covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Soligenix Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics Soligenix samples of Oragenics Soligenix Product sold by Oragenics Soligenix or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Soligenix Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.9, Intrexon shall notify the result of such inspection to Oragenics Soligenix in writing thereafter. Oragenics Soligenix shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 2 contracts

Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp), Exclusive Channel Collaboration Agreement (Intrexon Corp)

AutoNDA by SimpleDocs

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and shall ensure that the packaging, promotional materials, and labeling for Oragenics Products Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics shall ensure that Oragenics Products, or its their respective packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ use of the Intrexon Trademarks and patent markings shall be subject to prior Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. review and approval of the IPC. Oragenics acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics samples of Oragenics Product sold by Oragenics or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,9, Intrexon shall notify the result of such inspection to Oragenics in writing thereafter. Oragenics shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 1 contract

Samples: Exclusive Channel Collaboration Agreement (Intrexon Corp)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and shall ensure that the packaging, promotional materials, and labeling for Oragenics Products Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics shall ensure that Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission. Oragenics Products, or its their respective packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics samples of Oragenics Product sold by Oragenics or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.9, Intrexon shall notify the result of such inspection to Oragenics in writing thereafter. Oragenics shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 1 contract

Samples: Exclusive Channel Collaboration Agreement (Oragenics Inc)

Trademarks and Patent Marking. To the extent Histogenics elects to use Intrexon Trademarks in connection with Collaboration Products and to the extent permitted by applicable law and regulations, Oragenics shall, and Histogenics shall ensure that the packaging, promotional materials, and labeling for Oragenics Products Collaboration Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to OragenicsHistogenics’ reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics Histogenics shall ensure that Oragenics Collaboration Products, or its their respective packaging or accompanying literature as **** CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics Histogenics shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or such patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof, which approval shall not be unreasonably withheld, conditioned or delayed. OragenicsHistogenics’ use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics Histogenics acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics Histogenics covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Collaboration Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics Histogenics samples of Oragenics Collaboration Product sold by Oragenics Histogenics or its Affiliates or sublicenseesSublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, solely for the purpose of inspecting the quality of such Oragenics Collaboration Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.8, Intrexon shall notify the result of such inspection to Oragenics Histogenics in writing promptly thereafter. Oragenics Histogenics shall comply with reasonable policies provided by Intrexon in writing from time-to-time at least thirty (30) days prior to the due date of the obligation to comply to maintain the goodwill and value of the Intrexon Trademarks.

Appears in 1 contract

Samples: Exclusive Channel Collaboration Agreement (Histogenics Corp)

Trademarks and Patent Marking. To the extent permitted by applicable law and regulations, Oragenics shall, and Soligenix shall ensure that the packaging, promotional materials, and labeling for Oragenics Products Soligenix Products, as appropriate, shall carry, in a conspicuous location, the applicable Intrexon Trademark(s), subject to Oragenics’ Soligenix’s reasonable approval of the size, position, and location thereof. Consistent with the U.S. patent laws, Oragenics Soligenix shall ensure that Oragenics Soligenix Products, or its their respective packaging or accompanying literature as appropriate, bear applicable and appropriate patent markings for Intrexon Patent numbers. Oragenics Soligenix shall provide Intrexon with copies of any materials containing the Intrexon Trademarks or patent markings prior to using or disseminating such materials, in order to obtain Intrexon’s approval thereof. Oragenics’ Soligenix’s use of the Intrexon Trademarks and patent markings shall be subject to prior review and approval of the IPC. Oragenics Soligenix acknowledges Intrexon’s sole ownership of the Intrexon Trademarks and agrees not to take any action inconsistent with such ownership. Oragenics Soligenix covenants that it shall not use any trademark confusingly similar to any Intrexon Trademarks in connection with any products (including any Oragenics Soligenix Product). From time to time during the Term, Intrexon shall have the right to obtain from Oragenics Soligenix samples of Oragenics Soligenix Product sold by Oragenics Soligenix or its Affiliates or sublicensees, or other items which reflect public uses of the Intrexon Trademarks or patent markings, for the purpose of inspecting the quality of such Oragenics Soligenix Products, the use of the Intrexon Trademarks, or the accuracy of the patent markings. In the event that Intrexon inspects under this Section 4,94.9, Intrexon shall notify the result of such inspection to Oragenics Soligenix in writing thereafter. Oragenics Soligenix shall comply with reasonable policies provided by Intrexon from time-to-time to maintain the goodwill and value of the Intrexon Trademarks. Portions herein identified by [*****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A complete copy of this document has been filed separately with the Securities and Exchange Commission.

Appears in 1 contract

Samples: Exclusive Channel Collaboration Agreement (Soligenix, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!